GTMB 7 - Gene Therapy & Molecular Biology

More documents

Recommendations

Info

Xu et al: G-CSF receptor-mediated STAT3 activationStahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell JEJr andYancopoulos GD (1995) Choice of STATs and othersubstrates specified by modular tyrosine-based motifs incytokine receptors. Science 267, 1349-1353.Tian S-S, Lamb P, Seidel HM, Stein RB and Rosen J (1994)Rapid activation of the STAT3 transcription factor bygranulocyte colony-stimulating factor. Blood 84, 1760-1764.Tian S-S, Tapley P, Sincich C, Stein RB, Rosen J and Lamb P(1996) Multiple signaling pathways induced by granulocytecolony-stimulating factor involving activation of JAKs,STAT5, and/or STAT3 are required for regulation of threedistinct classes of immediate early genes. Blood 88, 4435-4444.Valtieri M, Tweardy DJ, Caracciolo D, Johnson K, Mavilio F,Altmann S, Santoli D and Rovera G (1987) Cytokinedependentgranulocytic differentiation: regulation ofproliferative and differentiative responses in a murineprogenitor cell line. J Immunol 138, 3829-3835.Ward AC, Smith L, de Koning JP, van Aesch Y and Touw IP(1999) Multiple signals mediate proliferation, differentiation,and survival from the granulocyte colony-stimulating factorreceptor in myeloid 32D cells. J Biol Chem 274, 14956-14962.Xu R, Kume A, Matsuda KM, Ueda Y, Kodaira H, OgasawaraY, Urabe M, Kato I, Hasegawa M and Ozawa K (1999) Aselective amplifier gene for tamoxifen-inducible expansionof hematopoietic cells. J Gene Med 1, 236-244.Yoshikawa A, Murakami H and Nagata S (1995) Distinct signaltransduction through the tyrosine-containing domains of thegranulocyte colony-stimulating factor receptor. EMBO J 14,5288-5296.Dr. Akihiro Kume172
Gene Therapy and Molecular Biology Vol 7, page 173Gene Ther Mol Biol Vol 7, 173-179, 2003.Calcium induces apoptosis and necrosis inhematopoetic malignant cells: Evidence for caspase-8 dependent and FADD-autonomous pathwayResearch ArticleChristof J. Burek † , Malgorzata Burek † , Johannes Roth # , and Marek Los †¨†Institute of Experimental Dermatology, University of Münster, D-48149 Münster; # Institute of Molecular Medicine,University of Düsseldorf, D-40225 Düsseldorf, Germany; ¨ Manitoba Institute of Cell Biology, CancerCare Manitoba,Winnipeg, Canada.__________________________________________________________________________________*Correspondence: Marek Los, MD/PhD, Institute of Experimental Dermatology, University of Münster, Röntgenstrasse 21, D-48149Münster, Germany; Phone: 49-251-83-52943; Fax: 49-251-83-56549; e-mail: los@uni-muenster.deKey Words: A23187, apoptosis, Bcl-2, caspase-8, FADD, necrosisAbbreviations: propidium iodide (PI), Fas-associated death domain protein (FADD), endoplasmic reticulum (ER), mitochondrialpermeability transition (MPT), apoptosis-inducing factor (AIF)Received: 1 September 2003; Accepted: 18 September 2003; electronically published: September 2003SummaryOne of the killing mechanisms employed by Natural Killer (NK) cells and Lymphokine-Activated Killer (LAK) cellsis the perforation of the cellular membrane that causes the increase of cytoplasmic calcium concentration anddisturbs further the homeostasis of other ions. Cytoplasmic calcium influx, exceeding the tolerated physiologicthreshold in cell signaling events, can induce either apoptosis or necrosis depending on its final concentration.Despite several years of intensive research and identification of some molecular targets of action like e.g. calpains,calcineurin or calreticulin, the exact mechanism of calcium-induced cell death is not known in detail. We show herethat death pathways triggered by calcium rely on a novel, caspase-8-dependent and Bcl-2-inhibitable pathway thatis FADD-adaptor molecule -independent. This is shown in a leukemic cell model. The experimental system employseither cells that lack the expression of casapase-8 or cells genetically modified to overexpress, Bcl-2, or a FADDdominantnegative mutant (FADD-DN).I. IntroductionCalcium is one of the most versatile and powerfulsmall molecules applied by a cell to regulate its biologicfunctions. It can either protect from or induce cell death,depending on concentration and cell type (Franklin andJohnson, 1992; Barros et al, 2002). Although themechanism of calcium triggered death has beeninvestigated for years, the exact mechanism(s) responsiblefor this process are not known in detail. Dying cells entereither apoptosis, necrosis or an intermediate form of celldeath, depending on the death stimulus, its intensity andthe level of intracellular ATP (Leist and Jaattela, 2001;Los et al, 2002). In accordance, calcium can induce bothforms of cell death as well as an intermediate process,depending on available intracellular concentration and celltype (Gwag et al, 1999; Barros et al, 2002). Calciumrelatedcell death is best described in neurones (Gwag etal, 1999; Xu et al, 2001), however, detailed studies inlymphatic tissue, from recent date are scarce. Calciumionophores, such as ionomycin or A-23187 are frequentlyapplied to manipulate intracellular Ca 2+ concentration andthus to mimic signaling events or to induce cell death(Errasfa and Stern, 1994; Nakamura, 1996). Severalauthors provide observations that various tumor cell linesexposed to A-23187 or ionomycin undergo either nonapoptoticdegeneration (Duke et al, 1994; Kressel andGroscurth, 1994), or classical apoptosis (Ojcius et al,1991; Ning and Murphy, 1993).Caspases (cysteine-dependent aspartases) are crucialapoptotic executioner proteases (Los et al, 1995; Herr andDebatin, 2001). They are members of the C14 proteasefamily according to the Barrett and Rawlings classification(Los et al, 1999; Barrett and Rawlings, 2001). All caspasesare characterized by a nearly absolute specificity forsubstrates containing aspartic acid in the P1 cleavageposition and a cysteine in the active center of the enzyme(Stennicke et al, 2002). There are currently 12 knowncaspases in humans. Caspases-1, -4 and -5 mainly play arole in the regulation of inflammatory response, byproteolytic activation of inflammatory cytokines (Cassenset al, 2003). Caspases-2, -3, -6, -7, -8, -9 and -10 are173
Page 7 and 8:
Instructions to authors:Gene Therap
Page 9:
Please submit an electronic version
Page 12:
103-111 ResearchArticle113-133 Revi
Page 17 and 18:
Gene Therapy and Molecular Biology
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77:
Page 80 and 81:
Epperly et al: Late injection of Mn
Page 82 and 83:
Epperly et al: Late injection of Mn
Page 84 and 85:
Goldberg-Cohen et al: Regulation of
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Gascón-Irún et al: Gene therapy a
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Suzuki et al: Regulation of the Sp/
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Li et al: MET amplification in live
Page 116 and 117:
Li et al: MET amplification in live
Page 118 and 119:
Chavakis et al: Leukocyte adhesion
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Sanlioglu et al: Adenovirus mediate
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137: Sanlioglu et al: Adenovirus mediate
Page 150 and 151: George et al: Gene therapy for vasc
Page 168 and 169: Zhang et al: Angiogenic Gene Therap
Page 182 and 183: Xu et al: G-CSF receptor-mediated S
Page 184 and 185: Xu et al: G-CSF receptor-mediated S
Page 188 and 189: Burek et al: Calcium induced cell d
Page 196 and 197: David et al: Current status and fut
Page 226 and 227: Stoll et al: The role of EBV and ge
Page 236 and 237:
Maruyama et al: Kidney-targeted pla
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Kren et al: Hepatocyte-targeted del
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Zeng: PRL-3 as a target for cancer
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Latchman: Protective effect of heat
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Cai et al: Lung cancer gene therapy
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309:
show all

GTMB 7 - Gene Therapy & Molecular Biology

Create successful ePaper yourself

Delete template?

Save as template?